Department of Orthopaedic Surgery, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Institute of Medical Sciences, Faculty of Health and Social Sciences, Canterbury Christ Church University, 30 Pembroke Court, Chatham Maritime, ME4 4UF, Kent, UK.
Knee Surg Sports Traumatol Arthrosc. 2020 Aug;28(8):2598-2603. doi: 10.1007/s00167-020-05884-y. Epub 2020 Feb 17.
The autologous collagen-induced chondrogenesis technique is described, and the results of a 6-year follow-up clinical study using this technique are presented.
30 patients with International Cartilage Repair Society (ICRS) Grade III/IVa symptomatic chondral defects of the knee treated with enhanced microdrilling using atelocollagen were prospectively examined in this clinical series. The median age of the patients was 39.0 years (range 19-61 years). Patients were followed up to 72 months. Clinical evaluation was performed using functional knee scores and radiologically. Both quantitative and qualitative assessments were performed.
Statistically significant and clinically relevant improvement was observed in 2 years and was sustained for the 6 years of the study observation. At 6 years, the mean Lysholm score was 79.7 (SD 6.8) compared to 52.6 (SD 10.7) pre-operatively (p < 0.05). The symptomatic Knee Injury and Osteoarthritis Outcome Score (KOOS) improved from 68.3 (SD 11.4) to 90.2 (SD 4.3) (p < 0.05). The subjective International Knee Documentation Committee (IKDC) also showed improvement from 39.1 (SD 4.1) to 81.6 (SD 7.8) (p < 0.05). The calculated T2* relaxation times were 26.0 (SD 4.2) seconds and 30.3 (SD 6.2) seconds for the repair tissue and native cartilage, respectively. The average magnetic resonance observation of cartilage repair tissue (MOCART) score was 78.5 (SD 9.6) for all lesions.
The enhanced microdrilling using atelocollagen is an enhancement of the traditional microfracture method using an off-the-shelf product. When used to treat moderate to severe chondral lesions, this enhancement produces hyaline-like cartilage with a corresponding improvement in symptoms.
IV.
介绍自体胶原诱导软骨形成技术,并呈现使用该技术进行的为期 6 年的临床研究结果。
本临床研究系列前瞻性检查了 30 例使用富含纤维蛋白的脱细胞胶原进行增强微钻孔治疗的、患有国际软骨修复学会(ICRS)III/IVa 级有症状的膝关节软骨缺损的患者。患者的中位年龄为 39.0 岁(19-61 岁)。患者随访时间达 72 个月。临床评估采用膝关节功能评分和影像学进行。同时进行定量和定性评估。
在第 2 年观察到具有统计学意义和临床相关的显著改善,并在研究观察的 6 年内持续存在。在第 6 年时,Lysholm 评分平均为 79.7(SD 6.8),与术前的 52.6(SD 10.7)相比有显著改善(p<0.05)。有症状的膝关节损伤和骨关节炎结果评分(KOOS)从 68.3(SD 11.4)改善至 90.2(SD 4.3)(p<0.05)。主观国际膝关节文献委员会(IKDC)也从 39.1(SD 4.1)改善至 81.6(SD 7.8)(p<0.05)。修复组织和正常软骨的 T2*弛豫时间分别为 26.0(SD 4.2)秒和 30.3(SD 6.2)秒。所有病变的平均磁共振软骨修复组织观察评分(MOCART)为 78.5(SD 9.6)。
富含纤维蛋白的脱细胞胶原增强微钻孔是传统微骨折方法的增强,使用现成产品。当用于治疗中重度软骨病变时,这种增强会产生类似透明软骨的组织,并相应改善症状。
IV。